Please assess the completion status of the following clinical trial:

Trial Title: Evaluation to Assess Cognitive Training for the Prevention of Post-operative Cognitive Decline

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Study groups~Inclusion Criteria:~* Pilot study: Female patients undergoing urogynecological or breast cancer surgery, screened at the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin, Berlin, Germany~* Age 18 years or older~* Montreal Cognitive Assessment Score (MOCA) \> 25~* Patient has access to Personal computer or Laptop with system software Windows XP Service Pack 3 (or newer); tablets or smart phones cannot by used.~* Written informed consent to participate after having been properly instructed~* Written informed consent that accidental clinically relevant diagnostic findings of MRI assessment are reported to the general practitioner of the patient~* Sufficient health insurance to cover additional diagnostic assessments in case of an accidental clinically relevant diagnostic finding of MRI assessment~Exclusion Criteria:~* Apparent dementia~* Lacking willingness to take part in the study, or to have relevant study data collected, saved and analyzed for the purpose of the study~* Lacking willingness to be contacted by telephone or mail.~* Accommodation in an institution due to an official or judicial order~* Insufficient knowledge of German language~* Members of the hospital staff~* Admitted in police custody~* Homelessness or other conditions that disable reachability for postoperative assessment by post or telephone~* Illiteracy~* Severe hearing impairment that affects the neuropsychological testing.~* Severe visual impairment that affects the neuropsychological testing.~* Participation in other prospective clinical interventional trials~* Daltonism~* Contra-indications against MRI assessment (claustrophobia, metallic implants, cardiac pacemaker, tatoos)~* Motor impairment that affects the use of a computer~* Regular use of psychotropic drugs (including sleep-inducing drugs and benzodiazepines) and substances which affect cognitive performance Control group~Inclusion Criteria:~24 female surgical control subjects from the POCD Register (EA1/104/169) and 24 female non-surgical control subjects

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Study group experimental (Type: EXPERIMENTAL): 24 female patients aged 18 years or older undergoing urogynecological or breast cancer surgery; the patients are recommended to perform the RehaCom® training modules 'Topological Memory (MEMO)' and 'Divided Attention 2 (GEA2)' daily during inpatient hospital stay, and at least three times a week for 30 to 60 minutes until month 3.
- Study group active comparator (Type: ACTIVE_COMPARATOR): 24 female patients aged 18 years or older undergoing urogynecological or breast cancer surgery; the patients are recommended to perform the RehaCom® training modules 'Topological Memory (MEMO)' and 'Working memory (WOME)' daily during inpatient hospital stay, and at least three times a week for 30 to 60 minutes until month 3.
- Control group (Type: NO_INTERVENTION): 48 female control subjects aged 18 years or older (24 without surgery, 24 with urogynecological or breast cancer surgery) with a similar health status and age as the study group patients (similar distribution in the American Society of Anaesthesiologists physical status classification and relevant co-morbidities, e.g. diabetes, coronary artery disease, hypertension and hyperlipidemia). The patients are analyzed to correct for learning effects of the cognitive assessment testings in the study groups.

Based on this trial design, predict the completion outcome and termination type (if applicable).